Autosomal dominant spastic paraplegia type 17 (Q100911)

From determinar.ia.br - Determine suas informações
Revision as of 17:41, 16 August 2026 by Determinaradmin (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Patients with spastic paraplegia type 17 develop spastic paraplegia associated with distal upper limb weakness and muscle atrophy. Age of onset is variable ranging from the first to seventh decade. The severity of the syndrome varies within families. Weakness is slowly progressive and patients may remain ambulant. The disease is caused by mutation of the BSCL2 gene (11q12.3).
Language Label Description Also known as
default for all languages
ID_465472056
    English
    Autosomal dominant spastic paraplegia type 17
    Patients with spastic paraplegia type 17 develop spastic paraplegia associated with distal upper limb weakness and muscle atrophy. Age of onset is variable ranging from the first to seventh decade. The severity of the syndrome varies within families. Weakness is slowly progressive and patients may remain ambulant. The disease is caused by mutation of the BSCL2 gene (11q12.3).

      Statements

      CID11:ID_465472056
      0 references
      dki-india-ID_465472056
      0 references
      Concluído
      0 references
      15 August 2026
      0 references